World Health Organization site
Skip Navigation Links
Advanced Search
List ByExpand List By
Search Tips
ICTRP websiteExpand ICTRP website
Contact us
                   5680 records for 1584 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
Not recruitingNoNCT03546192
Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)
Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT)
DISCOVER Global Registry
Not RecruitingYesCTRI/2018/05/013845
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents more than equal to 10 to less than 18 years with Type 2 Diabetes Mellitus
The Nueva Ecija Cardiovascular Risk Experiment
A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2017-001489-53-DE Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus 23/03/2018 
AuthorisedEUCTR2017-001489-53-LT Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus 19/03/2018 
A clinical study to assess the long-term safety and efficacy of Orelvo (voclosporin) compared with placebo in subjects with active lupus nephritis (LN)
A randomised, double-blind, parallel group, equivalence, multicentre phase III trial to compare the efficacy, safety and pharmakokinetics of HD201 to Herceptin® in patients with HER2+ early breast cancer 09/04/2018 
Study of durvalumab/placebo + chemoradiation Therapy in Patients with Locally Advanced Non-small Cell Lung Cancer
Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer
Recruitment statusMain IDPublic titleDate of registrationResults available
RecruitingJPRN-JapicCTI-183954 PACIFIC2 11/05/2018 
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history